FREE DOWNLOAD: Simple Options Trading For Beginners

From Profits Run | Ad

Avoid the account-crippling mistakes most rookies make with options trading...

...by using the simple steps to safely and profitably growing your account revealed in this free report.

(It's a quick read.)

Click to download.

ARQT Insider Trading (Arcutis Biotherapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 39.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,666,511.75

Arcutis Biotherapeutics Insider Trading History Chart

Arcutis Biotherapeutics Share Price & Price History

^$21.57

▼ -0.21 (-0.96%)

As of 10/22/2021 01:00 AM ET

Days: 30 | 90 | 365

GM and Toyota Shut Down

From Legacy Research | Ad

Once again, the word "Crisis" is being thrown around. But this is unlike anything we've seen before...

➔ Major automakers - from GM to Toyota are shutting their factories.
➔ Analysts are warning that Christmas, as we know it, may not happen this year.
➔ And massive food distributor, Sysco, says it's going to have trouble stocking grocery store shelves.

Not because of a recession or virus...not because of a new lockdown or war... But the very opposite. A new threat which could soon cause empty shelves as far as the eye can see.

Please... take the time to view this report

Arcutis Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/5/2021	Todd Franklin Watanabe	CEO	Sell	2,500	$24.92	$62,300.00
9/7/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.14	$21,140.00
8/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$20.81	$20,810.00
7/6/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.58	$46,515.00
7/1/2021	Howard G. Welgus	Director	Sell	2,200	$26.13	$57,486.00
6/24/2021	Bhaskar Chaudhuri	Director	Sell	729	$27.50	$20,047.50	848,146
6/21/2021	Bhaskar Chaudhuri	Director	Sell	2,516	$27.50	$69,190.00	848,875
6/7/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.35	$46,112.50
5/7/2021	Todd Franklin Watanabe	CEO	Sell	750	$35.00	$26,250.00
5/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$34.00	$59,500.00
4/20/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$28.06	$280,600.00	862,671
4/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$29.93	$52,377.50
4/1/2021	Howard G. Welgus	Director	Sell	2,200	$29.49	$64,878.00
3/22/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$31.10	$311,000.00	876,383
3/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$30.55	$53,462.50
2/10/2021	John W. Smither	CFO	Sell	750	$35.64	$26,730.00
2/1/2021	Bhaskar Chaudhuri	Director	Sell	9,949	$33.25	$330,804.25	901,340
2/1/2021	John W. Smither	CFO	Sell	1,250	$35.00	$43,750.00
1/29/2021	Bhaskar Chaudhuri	Director	Sell	51	$27.50	$1,402.50	901,340
1/19/2021	John W. Smither	CFO	Sell	500	$30.00	$15,000.00
12/1/2020	Howard G. Welgus	Director	Sell	2,200	$25.98	$57,156.00	180,234
10/1/2020	Howard G. Welgus	Director	Sell	2,200	$27.65	$60,830.00	179,210
9/29/2020	David W. Osborne	Insider	Sell	15,000	$30.00	$450,000.00
9/29/2020	John W. Smither	CFO	Sell	500	$30.00	$15,000.00
9/29/2020	Todd Franklin Watanabe	CEO	Sell	3,000	$30.00	$90,000.00	569,928
9/1/2020	Howard G. Welgus	Director	Sell	2,200	$24.38	$53,636.00	178,378
8/3/2020	Howard G. Welgus	Director	Sell	2,800	$25.63	$71,764.00	162,725
2/4/2020	Life Sciences Viii L Frazier	Major Shareholder	Buy	500,000	$24.10	$12,050,000.00
2/3/2020	Jonathan Silverstein	Director	Buy	558,888	$25.64	$14,329,888.32

Insider Trading at Arcutis Biotherapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Arcutis Biotherapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Arcutis Biotherapeutics (NASDAQ:ARQT)

90.35% of Arcutis Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Arcutis Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/14/2021	Hamilton Lane Advisors LLC	52,347	$1.25M	0.2%	-48.3%	0.104%
8/25/2021	Marshall Wace LLP	15,138	$0.41M	0.0%	-91.1%	0.030%
8/23/2021	Morgan Stanley	226,673	$6.19M	0.0%	+80.3%	0.451%
8/17/2021	Wells Fargo & Company MN	897,972	$24.51M	0.0%	+2.4%	1.787%
8/17/2021	Invesco Ltd.	12,085	$0.33M	0.0%	N/A	0.024%
8/17/2021	Metropolitan Life Insurance Co NY	7,875	$0.22M	0.0%	+131,150.0%	0.016%
8/17/2021	MetLife Investment Management LLC	10,548	$0.29M	0.0%	+27.9%	0.021%
8/17/2021	Price T Rowe Associates Inc. MD	924,958	$25.24M	0.0%	+40.9%	1.841%
8/16/2021	Bank of America Corp DE	6,533	$0.18M	0.0%	-84.6%	0.013%
8/16/2021	UBS Asset Management Americas Inc.	29,972	$0.82M	0.0%	+41.4%	0.060%
8/16/2021	Point72 Asset Management L.P.	896,400	$24.46M	0.1%	+104.1%	1.784%
8/16/2021	Cubist Systematic Strategies LLC	2,622	$72K	0.0%	-81.0%	0.005%
8/16/2021	California State Teachers Retirement System	38,143	$1.04M	0.0%	+9.4%	0.076%
8/16/2021	Royal Bank of Canada	2,053	$56K	0.0%	+59.8%	0.004%
8/16/2021	Morgan Stanley	226,673	$6.19M	0.0%	+80.3%	0.451%
8/16/2021	Credit Suisse AG	14,624	$0.40M	0.0%	-12.3%	0.029%
8/16/2021	Charles Schwab Investment Management Inc.	193,382	$5.28M	0.0%	+7.6%	0.385%
8/16/2021	State Street Corp	1,152,482	$31.45M	0.0%	+19.1%	2.294%
8/16/2021	Nuveen Asset Management LLC	263,846	$7.20M	0.0%	+18.3%	0.525%
8/16/2021	Goldman Sachs Group Inc.	31,759	$0.87M	0.0%	+48.4%	0.063%
8/16/2021	Marshall Wace LLP	15,138	$0.41M	0.0%	-91.1%	0.030%
8/13/2021	Northern Trust Corp	290,103	$7.92M	0.0%	+8.7%	0.577%
8/13/2021	Greenspring Associates LLC	35,210	$0.96M	0.1%	N/A	0.070%
8/13/2021	Altium Capital Management LP	231,314	$6.31M	1.5%	+103.0%	0.460%
8/13/2021	Laurion Capital Management LP	8,960	$0.25M	0.0%	-82.1%	0.018%
8/13/2021	Neuberger Berman Group LLC	121,216	$3.30M	0.0%	+1.3%	0.241%
8/13/2021	Franklin Resources Inc.	575,728	$15.71M	0.0%	-11.8%	1.146%
8/13/2021	Ensign Peak Advisors Inc	397,216	$10.84M	0.0%	+132.0%	0.791%
8/13/2021	AXA S.A.	243,364	$6.64M	0.0%	+8.4%	0.484%
8/13/2021	Geode Capital Management LLC	474,967	$12.96M	0.0%	+10.0%	0.945%
8/13/2021	Vanguard Group Inc.	1,494,276	$40.78M	0.0%	-2.3%	2.974%
8/13/2021	FMR LLC	7,530,740	$205.51M	0.0%	-1.4%	14.989%
8/13/2021	ProShare Advisors LLC	16,197	$0.44M	0.0%	+23.4%	0.032%
8/12/2021	Dimensional Fund Advisors LP	46,779	$1.28M	0.0%	N/A	0.093%
8/12/2021	Ballentine Partners LLC	7,377	$0.20M	0.0%	N/A	0.015%
8/12/2021	SG Americas Securities LLC	24,848	$0.68M	0.0%	+9.1%	0.049%
8/12/2021	Legal & General Group Plc	3,783	$0.10M	0.0%	-12.7%	0.008%
8/12/2021	The Manufacturers Life Insurance Company	16,119	$0.44M	0.0%	+24.2%	0.032%
8/11/2021	Commonwealth Equity Services LLC	10,309	$0.28M	0.0%	-6.2%	0.021%
8/11/2021	BlackRock Inc.	4,248,620	$115.95M	0.0%	+1.1%	8.463%
8/11/2021	Deutsche Bank AG	18,033	$0.49M	0.0%	+8.6%	0.036%
8/11/2021	Frazier Management LLC	8,434,232	$230.17M	21.2%	-20.0%	16.800%
8/10/2021	Virtus ETF Advisers LLC	7,692	$0.21M	0.1%	-25.3%	0.015%
8/10/2021	Principal Financial Group Inc.	11,562	$0.32M	0.0%	N/A	0.023%
8/10/2021	State Board of Administration of Florida Retirement System	7,976	$0.22M	0.0%	N/A	0.016%
8/10/2021	Citigroup Inc.	61,419	$1.68M	0.0%	+15.2%	0.122%
8/10/2021	Rafferty Asset Management LLC	37,761	$1.03M	0.0%	-9.4%	0.075%
8/9/2021	Meeder Asset Management Inc.	2,277	$62K	0.0%	+65.8%	0.005%
8/6/2021	PNC Financial Services Group Inc.	1,500	$40K	0.0%	N/A	0.003%
8/6/2021	Swiss National Bank	55,200	$1.51M	0.0%	-1.8%	0.110%
8/5/2021	American Century Companies Inc.	376,620	$10.28M	0.0%	+0.2%	0.750%
8/5/2021	Rhumbline Advisers	34,284	$0.94M	0.0%	+70.3%	0.068%
8/5/2021	Los Angeles Capital Management LLC	26,690	$0.73M	0.0%	N/A	0.053%
8/4/2021	IndexIQ Advisors LLC	13,984	$0.38M	0.0%	-6.2%	0.028%
8/2/2021	New York State Common Retirement Fund	23,892	$0.65M	0.0%	+31.3%	0.048%
8/2/2021	Advisor Group Holdings Inc.	2,764	$75K	0.0%	+291.5%	0.006%
7/30/2021	Alliancebernstein L.P.	18,800	$0.51M	0.0%	+37.2%	0.037%
5/19/2021	Squarepoint Ops LLC	10,649	$0.31M	0.0%	-78.3%	0.021%
5/18/2021	Millennium Management LLC	15,093	$0.44M	0.0%	-90.6%	0.030%
5/18/2021	Point72 Asset Management L.P.	439,300	$12.71M	0.1%	-49.8%	0.875%
5/18/2021	Morgan Stanley	125,712	$3.64M	0.0%	-17.3%	0.250%
5/18/2021	Cubist Systematic Strategies LLC	13,769	$0.40M	0.0%	+706.1%	0.027%
5/18/2021	Citadel Advisors LLC	452,456	$13.09M	0.0%	+238.4%	0.901%
5/18/2021	California State Teachers Retirement System	34,863	$1.01M	0.0%	+11.3%	0.069%
5/17/2021	Vivo Capital LLC	744,370	$21.54M	0.8%	-14.2%	1.483%
5/17/2021	Royal Bank of Canada	2,085	$60K	0.0%	+545.5%	0.004%
5/17/2021	Polar Capital Holdings Plc	1,557,543	$45.06M	0.3%	+101.0%	3.102%
5/17/2021	Price T Rowe Associates Inc. MD	656,421	$18.99M	0.0%	+149.8%	1.307%
5/17/2021	Ameriprise Financial Inc.	317,203	$9.18M	0.0%	+175.5%	0.632%
5/17/2021	Omega Fund Management LLC	623,836	$18.05M	2.5%	-2.6%	1.243%
5/17/2021	Pinz Capital Management LP	4,500	$0.13M	0.0%	N/A	0.009%
5/17/2021	Nuveen Asset Management LLC	223,008	$6.45M	0.0%	+23.5%	0.444%
5/17/2021	Goldman Sachs Group Inc.	21,397	$0.62M	0.0%	-90.5%	0.043%
5/14/2021	Pivotal bioVenture Partners Investment Advisor LLC	569,041	$16.46M	5.3%	-15.3%	1.133%
5/14/2021	Birchview Capital LP	9,000	$0.26M	0.2%	N/A	0.018%
5/14/2021	Occudo Quantitative Strategies LP	6,979	$0.20M	0.0%	-44.3%	0.014%
5/14/2021	Tekla Capital Management LLC	131,633	$3.81M	0.1%	N/A	0.262%
5/14/2021	TD Asset Management Inc.	33,655	$0.97M	0.0%	+293.4%	0.067%
5/14/2021	UBS Asset Management Americas Inc.	21,200	$0.61M	0.0%	N/A	0.042%
5/14/2021	Sectoral Asset Management Inc	878,948	$25.43M	1.9%	N/A	1.751%
5/14/2021	Credit Suisse AG	16,677	$0.48M	0.0%	-32.3%	0.033%
5/13/2021	Franklin Resources Inc.	653,008	$18.89M	0.0%	N/A	1.301%
5/13/2021	SG Americas Securities LLC	22,782	$0.66M	0.0%	N/A	0.045%
5/13/2021	Neuberger Berman Group LLC	119,670	$3.46M	0.0%	N/A	0.238%
5/13/2021	Bank of New York Mellon Corp	86,901	$2.51M	0.0%	+30.6%	0.173%
5/13/2021	Citigroup Inc.	53,332	$1.54M	0.0%	+882.5%	0.106%
5/13/2021	Martingale Asset Management L P	7,208	$0.21M	0.0%	N/A	0.014%
5/12/2021	Northern Trust Corp	266,818	$7.72M	0.0%	+11.1%	0.531%
5/12/2021	Geode Capital Management LLC	431,758	$12.49M	0.0%	+27.7%	0.860%
5/12/2021	Pura Vida Investments LLC	145,744	$4.22M	0.1%	N/A	0.290%
5/12/2021	Ensign Peak Advisors Inc	171,203	$4.95M	0.0%	+343.5%	0.341%
5/12/2021	E Fund Management Co. Ltd.	1,714	$50K	0.0%	N/A	0.003%
5/12/2021	UBS Group AG	20,446	$0.59M	0.0%	N/A	0.041%
5/10/2021	Rafferty Asset Management LLC	41,693	$1.21M	0.0%	+451.3%	0.083%
5/7/2021	BlackRock Inc.	4,201,959	$121.56M	0.0%	+45.1%	8.379%
5/7/2021	American International Group Inc.	13,471	$0.39M	0.0%	+11.9%	0.027%
5/7/2021	Alps Advisors Inc.	90,614	$2.62M	0.0%	+31.3%	0.181%
5/7/2021	Swiss National Bank	56,200	$1.63M	0.0%	+131.3%	0.112%
5/7/2021	IndexIQ Advisors LLC	14,910	$0.43M	0.0%	N/A	0.030%
5/6/2021	Arizona State Retirement System	7,152	$0.21M	0.0%	N/A	0.014%

Data available starting January 2016

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $21.57

$21.15

$21.85

50 Day Range

MA: $21.91

$19.28

$25.50

52 Week Range

Now: $21.57

$17.51

$38.49

Volume

59,959 shs

Average Volume

212,757 shs

Market Capitalization

$1.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.15

Who are the company insiders with the largest holdings of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top insider shareholders include:
Bhaskar Chaudhuri (Director)
Todd Franklin Watanabe (CEO)
Howard G Welgus (Director)
David W Osborne (Insider)
Howard G Welgus (Director)
John W Smither (CFO)
Jonathan Silverstein (Director)
Life Sciences Viii L Frazier (Major Shareholder)
Who are the major institutional investors of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top institutional shareholders include:
Hamilton Lane Advisors LLC — 0.10%
Which institutional investors are selling Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was sold by these institutional investors:
Hamilton Lane Advisors LLC
In the last year, company insiders that have sold Arcutis Biotherapeutics company stock include:
Bhaskar Chaudhuri (Director)
Todd Franklin Watanabe (CEO)
Howard G Welgus (Director)
David W Osborne (Insider)
Howard G Welgus (Director)